Home LiteratureArticle Details
PMID: 9811886 Published · ppublish English Journal Article

Impaired liver regeneration in inducible nitric oxide synthasedeficient mice.

Rai RM, Lee FY, Rosen A, Yang SQ, Lin HZ, Koteish A, Liew FY, Zaragoza C, Lowenstein C, Diehl AM

Abstract

The mechanisms that permit adult tissues to regenerate when injured are not well understood. Initiation of liver regeneration requires the injury-related cytokines, tumor necrosis factor (TNF) alpha and interleukin (IL) 6, and involves the activation of cytokine-regulated transcription factors such as NF-kappabeta and STAT3. During regeneration, TNFalpha and IL-6 promote hepatocyte viability, as well as proliferation, because interventions that inhibit either cytokine not only block hepatocyte DNA synthesis, but also increase liver cell death. These observations suggest that the cytokines induce hepatoprotective factors in the regenerating liver. Given evidence that nitric oxide can prevent TNF-mediated activation of the pro-apoptotic protease caspase 3 and protect hepatocytes from cytokine-mediated death, cytokine-inducible nitric oxide synthase (iNOS) may be an important hepatoprotective factor in the regenerating liver. In support of this hypothesis we report that the hepatocyte proliferative response to partial liver resection is severely inhibited in transgenic mice with targeted disruption of the iNOS gene. Instead, partial hepatectomy is followed by increased caspase 3 activity, hepatocyte death, and liver failure, despite preserved induction of TNFalpha, IL-6, NF-kappabeta, and STAT3. These results suggest that during successful tissue regeneration, injury-related cytokines induce factors, such as iNOS and its product, NO, that protect surviving cells from cytokine-mediated death.

MeSH Terms
Animals Cytokines/genetics,physiology Liver Regeneration/genetics Mice Mice, Knockout Nitric Oxide Synthase/deficiency,genetics Nitric Oxide Synthase Type II
Chemicals
Cytokines Nitric Oxide Synthase Nitric Oxide Synthase Type II Nos2 protein, mouse
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Rai R M
Department of Medicine, The Johns Hopkins University, Baltimore, MD 21205, USA.
Lee F Y
Rosen A
Yang S Q
Lin H Z
Koteish A
Liew F Y
Zaragoza C
Lowenstein C
Diehl A M
References (52)
52 references, click to expand
  1. Tolerance against tumor necrosis factor alpha (TNF)-induced hepatotoxicity in mice: the role of nitric oxide.
    Toxicol Lett. 1995 Dec;82-83:227-31 PMID: 8597057
  2. Liver regeneration.
    Science. 1997 Apr 4;276(5309):60-6 PMID: 9082986
  3. Amphibian limb regeneration: rebuilding a complex structure.
    Science. 1997 Apr 4;276(5309):81-7 PMID: 9082990
  4. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver.
    Hepatology. 1997 Apr;25(4):889-95 PMID: 9096593
  5. New tissues from old.
    Science. 1997 Apr 4;276(5309):15 PMID: 9122693
  6. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
    Br J Pharmacol. 1997 Mar;120(6):1067-74 PMID: 9134219
  7. In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: involvement of other cytokines.
    J Cell Biochem. 1997 Jun 1;65(3):349-58 PMID: 9138091
  8. Bile ducts and portal and central veins are major producers of tumor necrosis factor alpha in regenerating rat liver.
    Gastroenterology. 1997 Jun;112(6):2089-98 PMID: 9178702
  9. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
    Hepatology. 1997 Jun;25(6):1516-26 PMID: 9185777
  10. Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis.
    Am J Physiol. 1997 Jul;273(1 Pt 1):G124-30 PMID: 9252518
  11. Nuclear factor kappaB is required for the transcriptional control of type II NO synthase in regenerating liver.
    Biochem J. 1997 Sep 15;326 ( Pt 3):791-7 PMID: 9307029
  12. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide.
    Biochem Biophys Res Commun. 1997 Sep 18;238(2):387-91 PMID: 9299518
  13. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter.
    J Biol Chem. 1997 Sep 26;272(39):24417-25 PMID: 9305901
  14. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression.
    Arch Surg. 1997 Nov;132(11):1177-83 PMID: 9366709
  15. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms.
    J Biol Chem. 1997 Dec 5;272(49):31138-48 PMID: 9388267
  16. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation.
    Biochem Biophys Res Commun. 1997 Nov 17;240(2):419-24 PMID: 9388494
  17. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine.
    Am J Physiol. 1997 Dec;273(6 Pt 1):G1174-88 PMID: 9435542
  18. Nitric oxide. A key mediator in sepsis and endotoxaemia?
    J Physiol Pharmacol. 1997 Dec;48(4):493-506 PMID: 9444603
  19. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.
    J Biol Chem. 1998 Feb 13;273(7):4220-6 PMID: 9461619
  20. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.
    J Clin Invest. 1998 Feb 15;101(4):802-11 PMID: 9466975
  21. Evidence for a synergistic role of two types of human tumor necrosis factor receptors for the ligand-dependent activation of the nuclear transcription factor NF-kappaB.
    J Interferon Cytokine Res. 1998 Feb;18(2):117-23 PMID: 9506462
  22. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock.
    J Exp Med. 1998 Mar 16;187(6):917-28 PMID: 9500794
  23. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide.
    Nitric Oxide. 1997 Aug;1(4):275-81 PMID: 9441899
  24. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
    Hepatology. 1998 Oct;28(4):959-70 PMID: 9755232
  25. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death.
    J Exp Med. 1996 May 1;183(5):1957-64 PMID: 8642305
  26. Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes.
    J Biol Chem. 1996 Jul 26;271(30):17974-8 PMID: 8663327
  27. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats.
    Am J Physiol. 1996 Jun;270(6 Pt 1):G909-18 PMID: 8764196
  28. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.
    Proc Natl Acad Sci U S A. 1986 Mar;83(6):1670-4 PMID: 2419912
  29. Tumour necrosis factor increases hepatic cell mass.
    Br J Surg. 1991 Mar;78(3):331-3 PMID: 1902389
  30. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
    J Cell Biol. 1992 Nov;119(3):493-501 PMID: 1400587
  31. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy.
    Am J Physiol. 1992 Oct;263(4 Pt 1):G579-85 PMID: 1415718
  32. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3491-5 PMID: 7682706
  33. Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP.
    Genes Dev. 1993 Oct;7(10):1871-84 PMID: 8405996
  34. Tumor necrosis factor, other cytokines and disease.
    Annu Rev Cell Biol. 1993;9:317-43 PMID: 8280464
  35. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
    EMBO J. 1994 Mar 1;13(5):1189-96 PMID: 8131749
  36. Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes.
    Circ Res. 1994 Aug;75(2):285-95 PMID: 7518362
  37. Epr evidence of nitric oxide production by the regenerating rat liver.
    Biochem Biophys Res Commun. 1994 Jul 15;202(1):571-6 PMID: 8080556
  38. Nitric oxide production by cells isolated from regenerating rat liver.
    Biochem Biophys Res Commun. 1994 Nov 15;204(3):1305-11 PMID: 7980609
  39. Nitric oxide is released in regenerating liver after partial hepatectomy.
    Hepatology. 1995 Mar;21(3):776-86 PMID: 7533126
  40. Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappa B/Rel proteins.
    Biochem Biophys Res Commun. 1995 Apr 6;209(1):73-9 PMID: 7537042
  41. Altered immune responses in mice lacking inducible nitric oxide synthase.
    Nature. 1995 Jun 1;375(6530):408-11 PMID: 7539113
  42. Apoptosis and hepatobiliary disease.
    Hepatology. 1995 Jun;21(6):1725-41 PMID: 7768518
  43. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways.
    Hepatology. 1995 Dec;22(6):1829-37 PMID: 7489995
  44. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.
    Science. 1996 Nov 22;274(5291):1379-83 PMID: 8910279
  45. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters.
    J Biol Chem. 1996 Nov 22;271(47):30114-20 PMID: 8939960
  46. Alcohol and cytokine-inducible transcription factors.
    Alcohol Clin Exp Res. 1996 Dec;20(9):1639-45 PMID: 8986216
  47. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases.
    J Exp Med. 1997 Feb 17;185(4):601-7 PMID: 9034139
  48. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1441-6 PMID: 9037072
  49. The heat shock response inhibits inducible nitric oxide synthase gene expression by blocking I kappa-B degradation and NF-kappa B nuclear translocation.
    Biochem Biophys Res Commun. 1997 Feb 13;231(2):257-63 PMID: 9070260
  50. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression.
    Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2676-80 PMID: 9122255
  51. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.
    Immunity. 1997 Mar;6(3):315-25 PMID: 9075932
  52. In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6.
    Nucleic Acids Res. 1996 May 1;24(9):1682-7 PMID: 8649986
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1998-11-10
Pages
13829-34
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC24912
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com